Survey in pediatric ICU to reduce upfront vancomycin use
Part of Infections clinical trials.
This study is a survey and quality-improvement effort in participating children’s intensive care units. It aims to understand and change how doctors decide to start vancomycin (an antibiotic) when sepsis is suspected, to improve care and avoid unnecessary use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (the patient) must be admitted to a participating pediatric ICU during the study time period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a different way of giving vancomycin to children with sepsis to reduce the risk of kidney injury. It compares standard dosing to an approach that adjusts dose based on how the kidneys are working.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This study compares two ways of giving antibiotics to children with sepsis: the usual short infusions versus longer or continuous infusions. The goal is to see if one approach works better or is safer.
This study tracks how doctors treat septic shock in the ICU to learn what works best. If you have septic shock, joining this study helps researchers understand which treatments are most effective, and you'll get the same care you would anyway.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.